| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Foresite Capital Management V, LLC is 10% Owner at ALMS, with reported holdings spanning 2 companies.
Foresite Capital Management V, LLC's largest disclosed position is in LTGO as 10% Owner, worth about $49.7M. Net of sales, the LTGO filings show accumulation of 140,000 shares.
Foresite Capital Management V, LLC has 2 Form 4 filings on record from July 2024 to August 2026, across 2 companies: 10% Owner at Latigo Biotherapeutics (LTGO), 2026; 10% Owner at Alumis (ALMS), 2024.
The 25 reported transactions were 22 conversions and 3 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $42.5M and no sales.
The largest open-market purchase was 2,500,000 shares of ALMS at an average $16.00 on July 1, 2024, about $40.0M. Twelve months later ALMS was down 76%.